Add Yahoo as a preferred source to see more of our stories on Google. This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach requires chronic suppression of the immune system to prevent rejection of donor cells. A Vertex Pharmaceuticals ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

While it has long been known that type 1 diabetes runs in families, experts are less certain about what actually starts the autoimmune attack that defines the disease. Most people with type 1 diabetes ...

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...

Welcome, everyone, to the BioStock Studio where we today are doing this live webcast. Thank you for tuning in. So we are meeting today in the context of the World Diabetes Day. It's a day to raise ...